| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
33,206 |
27,774 |
$2.46M |
| 99215 |
Prolong outpt/office vis |
5,068 |
4,416 |
$512K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
10,722 |
10,200 |
$279K |
| 80305 |
|
18,719 |
16,541 |
$182K |
| 99408 |
|
9,134 |
8,754 |
$167K |
| 94010 |
|
6,522 |
5,831 |
$157K |
| 27096 |
|
1,458 |
1,249 |
$146K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,802 |
4,354 |
$143K |
| 96127 |
|
13,643 |
12,873 |
$138K |
| 99205 |
Prolong outpt/office vis |
670 |
637 |
$107K |
| 64493 |
|
1,642 |
1,420 |
$89K |
| 99443 |
|
863 |
780 |
$78K |
| 76942 |
|
1,098 |
917 |
$66K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,196 |
3,635 |
$61K |
| 64495 |
|
1,559 |
1,337 |
$56K |
| 64494 |
|
1,616 |
1,392 |
$53K |
| 99406 |
|
3,943 |
3,443 |
$36K |
| 62322 |
|
1,624 |
1,398 |
$35K |
| 20553 |
|
1,589 |
1,291 |
$33K |
| 64490 |
|
453 |
389 |
$30K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,602 |
1,389 |
$28K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
221 |
200 |
$26K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
441 |
393 |
$24K |
| 99152 |
|
1,111 |
921 |
$21K |
| 98928 |
|
635 |
480 |
$20K |
| 20611 |
|
932 |
556 |
$19K |
| 64492 |
|
417 |
355 |
$17K |
| 64491 |
|
485 |
413 |
$17K |
| 62320 |
|
456 |
389 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,320 |
1,260 |
$10K |
| 99153 |
Mod sedat endo service >5yrs |
463 |
403 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
645 |
587 |
$9K |
| 81007 |
|
325 |
312 |
$9K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
503 |
481 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
218 |
217 |
$4K |
| 99354 |
|
82 |
69 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,240 |
1,933 |
$3K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,486 |
2,148 |
$3K |
| 90686 |
|
175 |
167 |
$3K |
| 90674 |
|
81 |
79 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
25 |
25 |
$1K |
| 99385 |
|
13 |
12 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
404 |
369 |
$841.53 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
22 |
21 |
$701.80 |
| H0049 |
Alcohol and/or drug screening |
104 |
102 |
$622.80 |
| 99402 |
|
12 |
12 |
$607.53 |
| 64483 |
|
14 |
12 |
$527.80 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14 |
14 |
$481.97 |
| 96103 |
|
249 |
178 |
$400.34 |
| 64405 |
|
60 |
51 |
$362.39 |
| 81025 |
|
43 |
42 |
$327.18 |
| 64484 |
|
26 |
13 |
$251.07 |
| 20606 |
|
16 |
12 |
$219.42 |
| 64450 |
|
29 |
28 |
$89.30 |
| 99173 |
|
16 |
13 |
$29.11 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
151 |
141 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
165 |
143 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
207 |
190 |
$0.00 |